185 related articles for article (PubMed ID: 8570727)
21. Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.
Huang Z; Chen Q; Trncic N; LaRue SM; Brun PH; Wilson BC; Shapiro H; Hetzel FW
Radiat Res; 2004 Jun; 161(6):723-31. PubMed ID: 15161347
[TBL] [Abstract][Full Text] [Related]
22. The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study.
Selman SH; Keck RW
J Urol; 1994 Dec; 152(6 Pt 1):2129-32. PubMed ID: 7966701
[TBL] [Abstract][Full Text] [Related]
23. Choice of optimal wavelength for PDT: the significance of oxygen depletion.
Nielsen KP; Juzeniene A; Juzenas P; Stamnes K; Stamnes JJ; Moan J
Photochem Photobiol; 2005; 81(5):1190-4. PubMed ID: 15934793
[TBL] [Abstract][Full Text] [Related]
24. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
25. Light penetration in the human prostate: a whole prostate clinical study at 763 nm.
Moore CM; Mosse CA; Allen C; Payne H; Emberton M; Bown SG
J Biomed Opt; 2011; 16(1):015003. PubMed ID: 21280905
[TBL] [Abstract][Full Text] [Related]
26. Significantly increased lesion size by using the near-infrared photosensitizer 5,10,15,20-tetrakis (m-hydroxyphenyl)bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue.
Rovers JP; de Jode ML; Grahn MF
Lasers Surg Med; 2000; 27(3):235-40. PubMed ID: 11013385
[TBL] [Abstract][Full Text] [Related]
27. Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy.
Mallidi S; Anbil S; Bulin AL; Obaid G; Ichikawa M; Hasan T
Theranostics; 2016; 6(13):2458-2487. PubMed ID: 27877247
[TBL] [Abstract][Full Text] [Related]
28. Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate.
Xiao Z; Owen RJ; Liu W; Tulip J; Brown K; Woo T; Moore RB
Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):106-14. PubMed ID: 20510305
[TBL] [Abstract][Full Text] [Related]
29. Determination of the tumor tissue optical properties during and after photodynamic therapy using inverse Monte Carlo method and double integrating sphere between 350 and 1000 nm.
Honda N; Ishii K; Terada T; Nanjo T; Awazu K
J Biomed Opt; 2011 May; 16(5):058003. PubMed ID: 21639587
[TBL] [Abstract][Full Text] [Related]
30. An interstitial light assembly for photodynamic therapy in prostatic carcinoma.
Lee LK; Whitehurst C; Pantelides ML; Moore JV
BJU Int; 1999 Nov; 84(7):821-6. PubMed ID: 10532979
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy of the canine prostate: intra-arterial drug delivery.
Moore RB; Xiao Z; Owen RJ; Ashforth R; Dickey D; Helps C; Tulip J
Cardiovasc Intervent Radiol; 2008; 31(1):164-76. PubMed ID: 17962995
[TBL] [Abstract][Full Text] [Related]
32. Porphyrins in photodynamic therapy - a search for ideal photosensitizers.
Pushpan SK; Venkatraman S; Anand VG; Sankar J; Parmeswaran D; Ganesan S; Chandrashekar TK
Curr Med Chem Anticancer Agents; 2002 Mar; 2(2):187-207. PubMed ID: 12678743
[TBL] [Abstract][Full Text] [Related]
33. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer.
Davidson SR; Weersink RA; Haider MA; Gertner MR; Bogaards A; Giewercer D; Scherz A; Sherar MD; Elhilali M; Chin JL; Trachtenberg J; Wilson BC
Phys Med Biol; 2009 Apr; 54(8):2293-313. PubMed ID: 19305043
[TBL] [Abstract][Full Text] [Related]
34. Photosensitizers in prostate cancer therapy.
Gheewala T; Skwor T; Munirathinam G
Oncotarget; 2017 May; 8(18):30524-30538. PubMed ID: 28430624
[TBL] [Abstract][Full Text] [Related]
35. Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model.
Bozzini G; Colin P; Betrouni N; Maurage CA; Leroy X; Simonin S; Martin-Schmitt C; Villers A; Mordon S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):296-303. PubMed ID: 23993856
[TBL] [Abstract][Full Text] [Related]
36. Verdins in photodynamic therapy of squamous cell carcinoma.
Hayden RE; McLear PW; Morgan AR; Bischoff JK
Am J Otolaryngol; 1990; 11(2):125-30. PubMed ID: 2343995
[TBL] [Abstract][Full Text] [Related]
37. Differences between cytotoxicity in photodynamic therapy using a pulsed laser and a continuous wave laser: study of oxygen consumption and photobleaching.
Kawauchi S; Morimoto Y; Sato S; Arai T; Seguchi K; Asanuma H; Kikuchi M
Lasers Med Sci; 2004; 18(4):179-83. PubMed ID: 15042420
[TBL] [Abstract][Full Text] [Related]
38. Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer.
Huang Z; Chen Q; Luck D; Beckers J; Wilson BC; Trncic N; Larue SM; Blanc D; Hetzel FW
Lasers Surg Med; 2005 Jun; 36(5):390-7. PubMed ID: 15856509
[TBL] [Abstract][Full Text] [Related]
39. Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.
Johansson A; Axelsson J; Andersson-Engels S; Swartling J
Med Phys; 2007 Nov; 34(11):4309-21. PubMed ID: 18072496
[TBL] [Abstract][Full Text] [Related]
40. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.
Lilge L; Molpus K; Hasan T; Wilson BC
Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
